The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
about
Phytocannabinoids: a unified critical inventory.Medical cannabis: Another piece in the mosaic of autoimmunity?Novel Anti-fibrotic Therapies.Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice.Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
P2860
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@ast
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@en
type
label
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@ast
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@en
prefLabel
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@ast
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@en
P2093
P2860
P50
P921
P356
P1433
P1476
The cannabinoid quinol VCE-004 ...... ed receptor-γ and CB2 pathways
@en
P2093
Carmen del Río
Federica Pollastro
Giovanni Appendino
Irene Cantarero
Javier Fernández-Ruiz
Juan A Collado
M Luz Bellido
María Gómez-Cañas
P2860
P2888
P356
10.1038/SREP21703
P407
P577
2016-02-18T00:00:00Z
P5875
P6179
1016064282